• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Array BioPharma Inc

+ Add to Watchlist

AR2:GR

3.401 EUR 0.532 18.54%

As of 12:30:12 ET on 07/23/2014.

Snapshot for Array BioPharma Inc (AR2)

Open: 2.864 Day's Range: 2.864 - 3.401 Volume: 1,600
Previous Close: 2.869 52wk Range: 2.589 - 5.600 1-Yr Rtn: -28.82%

Stock Chart for AR2

No chart data available.
  • AR2:GR 3.401
  • 1D
  • 1M
  • 1Y
2.869
Interactive AR2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AR2

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) -0.6910
Est. PEG Ratio -
Market Cap (M EUR) 428.47
Shares Outstanding (M) 125.98
30 Day Average Volume 190
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AR2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AR2

Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

Ron SquarerChief Executive OfficerMichael N NeedleChief Medical Officer
R Michael CarruthersChief Financial OfficerNicholas A SaccomanoChief Scientific Officer
More Company Profile & Key Executives for AR2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil